Author

Finn Mier

Institutions: Institute of Pharmaceutical Sciences, University of Tübingen

Observed institutions: Institute of Pharmaceutical Sciences, University of Tübingen

ORCID: 0000-0003-3409-4626

Observed ORCID: 0000-0003-3409-4626

OpenAlex ID: A5114756921

A QM-AI Approach for the Acceleration of Accurate Assessments of Halogen-π Interactions by Training Neural Networks

2025 · Marc U. Engelhardt, Finn Mier, et al. · Journal of Chemical Information and Modeling · 5

Design, Synthesis, and Molecular Evaluation of S N Ar‐Reactive N ‐(6‐Fluoro‐3‐Nitropyridin‐2‐yl)Isoquinolin‐3‐Amines as Covalent USP7 Inhibitors Reveals an Unconventional Binding Mode

2025 · Larissa N. Ernst, Jason Stahlecker, et al. · Archiv der Pharmazie · 4

Comparison of QM Methods for the Evaluation of Halogen−π Interactions for Large-Scale Data Generation

2025 · Marc U. Engelhardt, Markus O. Zimmermann, et al. · Journal of Chemical Theory and Computation · 4

MCC: automated mass and charge curation at the genome scale applied to C. tuberculostearicum

2025 · Reihaneh Mostolizadeh, Finn Mier, et al. · Microbiology Spectrum · 3

Expanding and Enhancing Neural Network-Based QM-AI Models for the Accurate Prediction of Halogen-π Interaction Energies in Protein Contexts

2026 · Marc U. Engelhardt, Finn Mier, et al. · Journal of Chemical Information and Modeling · 2

Covalent drug rescue of multiple p53 mutants by stabilizing vinyl sulfone fragments hints to a specific refolding mechanism for R282W

2026 · Jason Stahlecker, Theresa Klett, et al. · Protein Science

Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells

2025 · Selina Maier, Werner Schroth, et al. · Journal of Biological Chemistry

Works count: 7

Citation count: 18

H-index: 3

I10-index: